Vannozzi MO - Search Results

1

Hydration regimen and hematological toxicity of a cisplatin-based chemotherapy regimen. Clinical observations and pharmacokinetic analysis.

Numico G, Benasso M, Vannozzi MO, Merlano M, Rosso R, Viale M, Esposito M. Numico G, et al. Among authors: vannozzi mo. Anticancer Res. 1998 Mar-Apr;18(2B):1313-8. Anticancer Res. 1998. PMID: 9615808

2

Pharmacokinetic and pharmacodynamic analysis of platinum after combined treatment of cisplatin and procainamide hydrochloride in mice bearing P388 leukemia.

Vannozzi MO, Ottone M, Mariggiò MA, Cafaggi S, Parodi B, Cilli M, Lindup E, Viale M. Vannozzi MO, et al. Anticancer Res. 2003 Mar-Apr;23(2B):1509-16. Anticancer Res. 2003. PMID: 12820417

3

Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats.

Esposito M, Vannozzi M, Viale M, Pellecchia C, Civalleri D, Gogioso L. Esposito M, et al. Anticancer Res. 1995 Nov-Dec;15(6B):2541-7. Anticancer Res. 1995. PMID: 8669820

4

Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer.

Nobile MT, Barzacch MC, Sanguineti O, Chiara S, Gozza A, Vincenti M, Lavarello A, Cognein P, Lionetto R, Percivale PL, Bertoglio S, Murolo C, Esposito M, Vannozzi MO, Rosso R. Nobile MT, et al. Among authors: vannozzi mo. Anticancer Res. 1998 Jan-Feb;18(1B):517-21. Anticancer Res. 1998. PMID: 9568171 Clinical Trial.

5

Sequence effect of epirubicin and paclitaxel treatment on pharmacokinetics and toxicity.

Venturini M, Lunardi G, Del Mastro L, Vannozzi MO, Tolino G, Numico G, Viale M, Pastrone I, Angiolini C, Bertelli G, Straneo M, Rosso R, Esposito M. Venturini M, et al. Among authors: vannozzi mo. J Clin Oncol. 2000 May;18(10):2116-25. doi: 10.1200/JCO.2000.18.10.2116. J Clin Oncol. 2000. PMID: 10811677

6

Time-dependent influence of procaine hydrochloride on cisplatin antitumor activity in P388 tumor bearing mice.

Viale M, Vánnozzi MO, Mandys V, Esposito M. Viale M, et al. Among authors: vannozzi mo. Anticancer Res. 2001 Jan-Feb;21(1A):485-7. Anticancer Res. 2001. PMID: 11299784

7

Regional pharmacokinetic selectivity of intrapleural cisplatin.

Bogliolo GV, Lerza R, Bottino GB, Mencoboni MP, Pannacciulli IM, Vannozzi M, Fulco RA, Merlo F, Esposito M. Bogliolo GV, et al. Eur J Cancer. 1991;27(7):839-42. doi: 10.1016/0277-5379(91)90129-2. Eur J Cancer. 1991. PMID: 1834113

8

Effect of normal saline on cisplatin pharmacokinetics and antitumor activity in mice bearing P388 leukemia.

Fulco RA, Vannozzi M, Collecchi P, Merlo F, Parodi B, Civalleri D, Esposito M. Fulco RA, et al. Anticancer Res. 1990 Nov-Dec;10(6):1603-10. Anticancer Res. 1990. PMID: 2285232

9

Chemical and biological properties of a new cis-diammineplatinum (II) complex containing para-aminobenzoic acid as amino ligand.

Parodi B, Esposito M, Viale M, Cafaggi S, Vannozzi M. Parodi B, et al. Anticancer Res. 1995 May-Jun;15(3):895-9. Anticancer Res. 1995. PMID: 7645978

10

Cis-diamminedichloroplatinum (II)-procaine pharmacokinetic interaction in mice bearing P388 leukemia.

Esposito M, Vannozzi MO, Viale M, Pellecchia C, Merlo F, Cadoni A, Cafaggi S, Parodi B, Lerza R, Poirier MC. Esposito M, et al. Among authors: vannozzi mo. Anticancer Res. 1993 Sep-Oct;13(5A):1511-6. Anticancer Res. 1993. PMID: 8239529

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters